Clarius brings ultrasound images into the palm of your hand

Clarius Mobile Health, a manufacturer of digital healthcare devices, has developed a portable ultrasound scanner that pairs with smartphones and tablets to provide real-time imaging for emergency services.

The Clarius device uses wireless ultrasound scanners to communicate with the corresponding mobile application, available on Apple and android smartphones as well as tablets. The devices comes in two formats—the C3 is designed to image the abdomen, lungs and heart and the L7 is meant for procedures regarding nerve blocks and targeted injections.

"One of the biggest obstacles to providing emergency care in the field is the lack of diagnostic tools," said Branden Miesemer, a flight paramedic and medical educator in Nebraska. "Having the ability to use real-time ultrasound imaging in the field will help improve treatment and patient outcomes."

The device has a magnesium case, rechargeable battery and is water resistant. The device is intended to take images of critically ill patients on their way to the hospital. Currently awaiting FDA approval, the device is being used as a teaching tool on models.

"We are seeing strong interest from the [emergency medical services] community, and I believe Clarius will be a great fit," said Laurent Pelissier, Chairman and CEO of Clarius Mobile Health. "It's super portable, durable, easy to use and produces excellent images. It will be priced so institutions can buy several for the price of a high quality portable ultrasound system."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup